It’s only a matter of time before drugs are administered via patches with painless microneedles instead of unpleasant injections. But designers need to balance the need for flexible, comfortable-to-wear material with effective microneedle penetration of the skin. Swedish researchers say they may have cracked the problem.
In a recent study published in PLOS ONE, a research team from KTH Royal Institute of Technology in Stockholm reports a successful test of its microneedle patch, which combines stainless steel needles embedded in a soft polymer base – the first such combination believed to be scientifically studied. The soft material makes it comfortable to wear, while the stiff needles ensure reliable skin penetration.
Unlike epidermal patches, microneedles penetrate the upper layer of the skin, just enough to avoid touching the nerves. This enables delivery of drugs, extraction of physiological signals for fitness monitoring devices, extracting body fluids for real-time monitoring of glucose, pH level and other diagnostic markers, as well as skin treatments in cosmetics and bioelectric treatments.
Frank Niklaus, professor of micro and nanofabrication at KTH, says that practically all microneedle arrays being tested today are “monoliths”, that is, the needles and their supporting base are made of the same – often hard and stiff – material. While that allows the microneedles to penetrate the skin, they are uncomfortable to wear. On the other hand, if the whole array is made from softer materials, they may fit more comfortably, but soft needles are less reliable for penetrating the skin.
“To the best of our knowledge, flexible and stretchable patches with arrays of sharp and stiff microneedles have not been demonstrated to date,” he says.
They actually tested two variations of their concept, one which was stretchable and slightly more flexible than the other. The more flexible patch, which has a base of molded thiol-ene-epoxy-based thermoset film, conformed well to deformations of the skin surface and each of the 50 needles penetrated the skin during a 30 minute test.
A successful microneedle product could have major implications for health care delivery. “The chronically ill would not have to take daily injections,” says co-author Niclas Roxhed, who is research leader at the Department of Micro and Nanotechnology at KTH.
In addition to addressing people’s reluctance to take painful shots, microneedles also offer a hygiene benefit. The World Health Organization estimates that about 1.3 million people die worldwide each year due to improper handling of needles.
“Since the patch does not enter the bloodstream, there is less risk of spreading infections,” Roxhed says.
Learn more: Painless microneedle patch could replace needles
Receive an email update when we add a new MICRONEEDLE article.
The Latest on: Microneedle patch
via Google News
The Latest on: Microneedle patch
- Manufacturing Microneedle Array Patches for Vaccine Deliveryon May 4, 2020 at 1:02 pm
Microneedle patches have been studied in a clinical trial for delivering a flu vaccine (1) and in preclinical trials for delivering inactivated rotavirus vaccine (IRV) and co-administration of IRV and ...
- Hyalo Deep Patches erase wrinkles under your eyeson May 3, 2020 at 1:23 pm
Millions of people peer into the mirror every morning and wonder if anything can be done about the lines under their eyes. They’re caused by a lack of hyaluronic acid, which keeps the skin moisturized ...
- Napa company begins testing a potential COVID-19 vaccineon April 30, 2020 at 4:02 pm
Verndari’s VaxiPatch is a complete single-dose vaccination kit that uses a dermal patch with a microneedle array to deliver vaccines to the arm. The patch itself is a big deal because the ...
- Taking the sting out of vaccine deliveryon April 29, 2020 at 5:26 pm
I am working on delivery systems for vaccines that either use microneedles, where you put a patch on your skin and the vaccine gets delivered painlessly that way, or else the vaccine can be taken ...
- Verndari, Inc. Begins Preclinical Testing of COVID-19 Vaccine at University of California, Davison April 29, 2020 at 3:49 pm
Napa biotech’s new COVID-19 vaccine begins testing this week at UC Davis. Verndari, Inc.’s vaccine designed to be given via microneedle dermal patch.
- Verndari, Inc. Begins Preclinical Testing of COVID-19 Vaccine at University of California, Davison April 29, 2020 at 10:21 am
Vaccine will be delivered via a dermal patch applied to skin Verndari’s VaxiPatch™ microneedle patch technology enables mass production of vaccination kits Verndari, Inc., a biopharmaceutical ...
- COVID-19 vaccine with patch delivery technology enters preclinical testingon April 29, 2020 at 9:13 am
Verndari Inc., a stage biopharmaceutical company, announced today that it will begin preclinical testing this week at UC Davis' Mouse Biology Program to evaluate a potential vaccine and delivery ...
- Verndari, Inc. Begins Preclinical Testing of COVID-19 Vaccine at University of California, Davison April 29, 2020 at 6:56 am
Verndari’s unique VaxiPatch™ is a complete single-dose vaccination kit that uses a dermal patch with a microneedle array to deliver vaccines to the arm. The technology eliminates the need for ...
- COVID-19 Vaccine With Patch Delivery Technology Enters Preclinical Testing at UC Davison April 29, 2020 at 6:56 am
Verndari Inc., a biopharmaceutical company, announced today that it will begin preclinical testing this week at UC Davis’ Mouse Biology Program to evaluate a potential vaccine and delivery system for ...
via Bing News